UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
WASHINGTON, DC 20549
FORM 8-K
CURRENT REPORT
Pursuant to Section 13 or 15(d) of the
Securities Exchange Act of 1934
Date of report (Date of
earliest event reported): May 17, 2019
MEDPACE HOLDINGS, INC.
(Exact Name of Registrant as Specified in
Charter)
|
|
|
|
|
|
|
Delaware
|
|
001-37856
|
|
32-0434904
|
|
(State or Other Jurisdiction
of Incorporation)
|
|
(Commission
File Number)
|
|
(I.R.S. Employer
Identification No.)
|
|
|
|
|||
5375 Medpace Way
Cincinnati, Ohio 45227
(Address of Principal Executive Offices, and Zip Code)
(513) 579-9911
Registrant’s Telephone Number, Including Area Code
Not Applicable
(Former Name or Former Address, if Changed
Since Last Report)
Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the
registrant under any of the following provisions (see General Instruction A.2. below):
|
|
☐
|
Written communication pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
|
|
|
☐
|
Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
|
|
|
☐
|
Pre-commencement communication pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))
|
|
|
☐
|
Pre-commencement communication pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))
|
Securities registered pursuant to Section 12(b) of the Act:
|
Title of each class
|
Trading Symbol(s)
|
Name of each exchange on which registered
|
|
Common Stock
|
MEDP
|
Nasdaq Global Select Market
|
Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of
1933 (17 CFR §230.405) or Rule 12b-2 of the Securities Exchange Act of 1934 (17 CFR §240.12b-2).
Emerging growth company ☒
If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with
any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☒
Item 5.07. Submission of Matters to a Vote of Security Holders.
On May 17, 2019, Medpace Holdings, Inc. (the “Company”) held its 2019 Annual Meeting of Stockholders. As of March 25,
2019, the record date for the Annual Meeting, there were 35,826,222 shares of Common Stock outstanding and entitled to vote at the Annual Meeting. A quorum was present at the Annual Meeting, as required by the Company’s Amended and Restated
Bylaws.
Proposal 1 — Election of a Director
The following individual was elected to the Company’s Board of Directors to serve as a Class III Director until the Company’s 2022 Annual
Meeting of Stockholders, and until his successor shall have been duly elected and qualified.
|
|
|
Votes
For |
|
Votes
Withheld |
|
Broker
Non-Votes |
|
|
August J. Troendle
|
|
22,798,618
|
|
8,820,127
|
|
1,705,210
|
|
Proposal 2 — Ratification of Appointment of
Independent Registered Public Accounting Firm
The appointment of Deloitte & Touche LLP as the Company’s independent registered public accounting firm for the fiscal year ending
December 31, 2019 was ratified.
|
Votes
For |
|
Votes
Against |
|
Votes
Abstained |
Broker
Non-Votes |
|
|
33,090,307
|
|
222,922
|
|
10,726
|
N/A
|
SIGNATURE
Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this
report to be signed on its behalf by the undersigned hereunto duly authorized.
|
MEDPACE HOLDINGS, INC.
|
||||||
|
Date:
|
May 17, 2019
|
By:
|
/s/ Stephen P. Ewald
|
|||
|
Name:
|
Stephen P. Ewald
|
|||||
|
Title:
|
General Counsel and Corporate Secretary
|
|||||